rs11568345

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_014585.6(SLC40A1):​c.327C>T​(p.Ile109Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00415 in 1,613,972 control chromosomes in the GnomAD database, including 254 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. I109I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.023 ( 133 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 121 hom. )

Consequence

SLC40A1
NM_014585.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.510

Publications

2 publications found
Variant links:
Genes affected
SLC40A1 (HGNC:10909): (solute carrier family 40 member 1) The protein encoded by this gene is a cell membrane protein that may be involved in iron export from duodenal epithelial cells. Defects in this gene are a cause of hemochromatosis type 4 (HFE4). [provided by RefSeq, Jul 2008]
SLC40A1 Gene-Disease associations (from GenCC):
  • hemochromatosis type 4
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 2-189572906-G-A is Benign according to our data. Variant chr2-189572906-G-A is described in ClinVar as [Benign]. Clinvar id is 333171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.51 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0771 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC40A1NM_014585.6 linkc.327C>T p.Ile109Ile synonymous_variant Exon 4 of 8 ENST00000261024.7 NP_055400.1 Q9NP59
SLC40A1XM_047444066.1 linkc.207C>T p.Ile69Ile synonymous_variant Exon 4 of 8 XP_047300022.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC40A1ENST00000261024.7 linkc.327C>T p.Ile109Ile synonymous_variant Exon 4 of 8 1 NM_014585.6 ENSP00000261024.3 Q9NP59
SLC40A1ENST00000479598.5 linkn.608C>T non_coding_transcript_exon_variant Exon 4 of 4 1
SLC40A1ENST00000427241.5 linkc.327C>T p.Ile109Ile synonymous_variant Exon 6 of 8 5 ENSP00000390005.1 E7ES28

Frequencies

GnomAD3 genomes
AF:
0.0228
AC:
3474
AN:
152142
Hom.:
133
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0795
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00864
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.0172
GnomAD2 exomes
AF:
0.00596
AC:
1499
AN:
251378
AF XY:
0.00439
show subpopulations
Gnomad AFR exome
AF:
0.0831
Gnomad AMR exome
AF:
0.00341
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00245
GnomAD4 exome
AF:
0.00220
AC:
3222
AN:
1461712
Hom.:
121
Cov.:
31
AF XY:
0.00187
AC XY:
1360
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.0797
AC:
2667
AN:
33468
American (AMR)
AF:
0.00434
AC:
194
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.000162
AC:
14
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000522
AC:
58
AN:
1111882
Other (OTH)
AF:
0.00459
AC:
277
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
169
338
506
675
844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0229
AC:
3480
AN:
152260
Hom.:
133
Cov.:
32
AF XY:
0.0217
AC XY:
1619
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0794
AC:
3297
AN:
41524
American (AMR)
AF:
0.00863
AC:
132
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68028
Other (OTH)
AF:
0.0170
AC:
36
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
159
318
477
636
795
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00793
Hom.:
81
Bravo
AF:
0.0272
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hemochromatosis type 4 Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
9.0
DANN
Benign
0.77
PhyloP100
0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11568345; hg19: chr2-190437632; API